A copper based enzyme-free fluorescence ELISA for HER2 detection

Area of Science:

• Biochemistry
• Nanotechnology
• Clinical Diagnostics

Background:

• Traditional ELISA methods for biomarker detection often rely on enzymes, which can be costly and unstable.
• Accurate detection of breast cancer biomarkers like human epidermal growth factor receptor 2 (HER2) is crucial for early diagnosis and treatment.

Purpose of the Study:

• To develop a sensitive, selective, and cost-effective enzyme-free immunoassay for detecting HER2 in human serum.
• To utilize copper oxide (CuO) nanoparticles as a signal probe in an ELISA format.

Main Methods:

• An enzyme-free ELISA was designed using CuO nanoparticles as signal probes.
• CuO nanoparticles were dissolved in acid to generate Cu (II) ions.
• Cu (II) ions catalyzed a reaction producing fluorescent quinoxaline derivatives for detection.
• The assay's performance was evaluated for sensitivity, selectivity, and application in breast cancer patient serum samples.

Main Results:

• The enzyme-free immunoassay demonstrated high sensitivity and selectivity for HER2 detection.
• A low limit of detection (LOD) of 9.65 pg·mL^-1 was achieved.
• The assay successfully analyzed HER2 levels in breast cancer patient serum samples.
• Results showed good agreement with a commercial HER2 ELISA kit.

Conclusions:

• The developed enzyme-free ELISA using CuO nanoparticles is a simple, sensitive, and cost-effective method for HER2 detection.
• This assay offers advantages over traditional enzyme-based methods due to the stability and low cost of CuO nanoparticles.
• The assay shows significant potential for widespread clinical application in breast cancer diagnostics and can be adapted for other analytes.